Incidence and severity of hypoglycaemia in type 2 diabetes by treatment regimen: A UK multisite 12-month prospective observational study.

Alison J DunkleyClaire FitzpatrickLaura J GrayGhazala WaheedSimon R Heller Brian M Frier Melanie Jane Davies Kamlesh Khunti F MedScinull null

Published in: Diabetes, obesity & metabolism (2019)

Hypoglycaemia represents a substantial burden for people with type 2 diabetes. Sulphonylureas and insulin are both associated with a risk of reported non-severe hypoglycaemia, but only insulin with severe episodes. This suggests the importance of the continued use of sulphonylureas in appropriate patients with type 2 diabetes.

Keyphrases

type diabetes
glycemic control
early onset
risk factors
cardiovascular disease
insulin resistance
cross sectional
adipose tissue
skeletal muscle
weight loss